Diffucing capacity for carbon monoxide (DLCO) is a commonly performed and clinically useful pulmonary function test that provides a quantitative measure of gas transfer in the lungs; it is often abnormal in patients with ILD. It has been known that there is a relationship between the development...
The effects of obesity on pulmonary function examination, standardised pulmonary function tests (spirometry, lung volumes, and single breath diffusion capacity for carbon monoxide), and DEXA scan ... AM Li,D Chan,E Wong,... - 《Archives of Disease in Childhood》 被引量: 1061发表: 2003年 ...
aIn addition to the assessment of comorbidities, pulmonary function testing provides useful information on the patients’ ability to tolerate the physiologic consequences of lung resection. For patients with compromised pulmonary function, a Technetium (99mTc) microalbumin aggregated lung perfusion study can...
dyspnea on exertion that is clinically out of proportion to the FEV1, the diffusing capacity of the lung for carbon monoxide (Dlco) should also be ... GL Colice,S Shafazand,JP Griffin,... - 《Chest》 被引量: 935发表: 2007年 Pulmonary function testing in idiopathic interstitial pneumonia...
To read more about what our CEO, pulmonary health experts and featured writers have to say about DLCO, click here.
The single-breath diffusing capacity of the lung (DLCO) is a commonly performed pulmonary function test. This standardized method for DLCO measurement is based on a full inspiration of a DLCO test gas mix followed by a breath hold phase and a full expiration. The DLCO test gas mix normally ...
The single-breath diffusing capacity of the lung (DLCO) is a commonly performed pulmonary function test. This standardized method for DLCO measurement is based on a full inspiration of a DLCO test gas mix followed by a breath hold phase and a full expiration. The DLCO test gas mix normally ...
behaviour of the respiratory system under stress on the basis of the lung carbon monoxide diffusing (DLCO) measured during effort in attempt to identify possible sub-clinical impairment.MethodsWere enrolled 20 SSc patients with limited forms (SScl) with normal pulmonary HRCT and 20 healthy controls...
The pulmonary function test (PFT), including spirometry and diffusing capacity (DLCO), was performed before and after three months of EGFR-TKI therapy. After three months, the patients were divided into groups based on the Response Evaluation Criteria in Solid Tumors (RECIST) criteria and the ...
The DLCO may be a useful pulmonary function test to assist in the differentiation of CLAD phenotypes, especially when volumetric or radiologic measurements are unavailable.doi:10.1016/j.healun.2020.01.685D.R. DarleyJ. MaL. LevyE. Huszti